Jump to content

Pipeline

Sign in to follow this  
Medikamente in Entwicklung

25 Einträge

  1. BTT-1023

    Indikation: Yes Phase: Yes
    • 0 comments
    • 2,160 views
  2. C15

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,609 views
  3. CM2489

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,559 views
  4. CPSI-2364

    Weiterer Name: Semapimod Indikation: Yes Phase: Yes
    • 0 comments
    • 1,589 views
  5. CT-P05

    Indikation: Yes Phase: No
    • 0 comments
    • 1,792 views
  6. CT-P17

    Indikation: Yes Phase: No
    • 0 comments
    • 2,121 views
  7. DPS-101

    Weiterer Name: Dermipsor Indikation: Yes Phase: Yes
    • 0 comments
    • 1,584 views
  8. GSK2586184

    Weiterer Name: früher: GLPG0778 Indikation: Yes Phase: Yes
    • 0 comments
    • 1,219 views
  9. HBP-348

    Weiterer Name: Hypericin Indikation: Yes Phase: Yes
    • 0 comments
    • 1,356 views
  10. IMO-3100

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,462 views
  11. INCB 18424

    Weiterer Name: Ruxolitinib Indikation: Yes Phase: Yes
    • 0 comments
    • 1,528 views
  12. MEDI-545

    Weiterer Name: MDX-1103 Indikation: Yes Phase: No
    • 0 comments
    • 1,218 views
  13. MT-1303

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,177 views
  14. MT203

    Weiterer Name: Namilumab Indikation: Yes Phase: No
    • 0 comments
    • 1,289 views
  15. P-3073

    Indikation: No Phase: Yes
    • 0 comments
    • 1,189 views
  16. PAP-1

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,125 views
  17. PH-10

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,214 views
  18. ProtoCure

    Indikation: Yes Phase: No
    • 0 comments
    • 1,047 views
  19. RhuDex

    Indikation: Yes Phase: No
    • 0 comments
    • 1,002 views
  20. Roflumilast dermal

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,192 views
  21. Rossoseq

    Indikation: Yes Phase: No
    • 0 comments
    • 1,311 views
  22. RTU-1096

    Indikation: No Phase: Yes
    • 0 comments
    • 964 views
  23. TA-650

    Indikation: Yes Phase: Yes
    • 0 comments
    • 1,362 views
  24. TRX4

    Weiterer Name: Otelixizumab Indikation: Yes Phase: No
    • 0 comments
    • 1,123 views
  25. VH

    Indikation: Yes Phase: No
    • 0 comments
    • 794 views
Sign in to follow this  
×